Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-09

FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental NDA for Tenormin (atenolol) submitted by Almatica Pharma LLC, authorizing a supplemental labeling/indication update for the beta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TENORMIN (ATENOLOL)

Snippet

SUPPL AP for TENORMIN (ATENOLOL)